Genelux names Jason Litten as chief medical officer
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chimeric Therapeutics Ltd (CHM)
Chimeric Therapeutics Ltd stock price live, this page displays ASX CHM stock exchange data. View the CHM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chimeric Therapeutics Ltd real time stock price chart below.
What Is the Chimeric Therapeutics Ltd Stock Price Today?
The Chimeric Therapeutics Ltd stock price today is 0.13.
What Is the Stock Symbol for Chimeric Therapeutics Ltd?
The stock symbol for Chimeric Therapeutics Ltd is "CHM."
What Stock Exchange Does Chimeric Therapeutics Ltd Trade On?
Chimeric Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Chimeric Therapeutics Ltd a Good Stock to Buy?
Determining whether Chimeric Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CHM quote. (ISIN: AU0000121576)
What Is the Chimeric Therapeutics Ltd Stock Price Today?
The Chimeric Therapeutics Ltd stock price today is 0.13.
What Is the Stock Symbol for Chimeric Therapeutics Ltd?
The stock symbol for Chimeric Therapeutics Ltd is "CHM."
What Stock Exchange Does Chimeric Therapeutics Ltd Trade On?
Chimeric Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Chimeric Therapeutics Ltd a Good Stock to Buy?
Determining whether Chimeric Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CHM quote. (ISIN: AU0000121576)
Sydney
Currency in AUD
0.13
+0.01(+4.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.13
0.13
52 wk Range
0.10
0.60
CHM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.130.13
52 wk Range
0.100.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CHM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Earnings
Latest Release
Feb 27, 2026
EPS / Forecast
-- / --
Revenue / Forecast
2.62M / --
Compare CHM to Peers and Sector
Metrics to compare | CHM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCHMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −5.5x | −0.5x | |
PEG Ratio | −0.01 | −0.05 | 0.00 | |
Price/Book | −2.2x | 1.7x | 2.6x | |
Price / LTM Sales | 0.7x | 16.3x | 3.1x | |
Upside (Analyst Target) | - | 197.6% | 55.1% | |
Fair Value Upside | Unlock | 21.4% | 7.2% | Unlock |
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. It also develops CHM CORE-NK for the treatment of acute myeloid leukaemia/colorectal cancer, acute myeloid cancer, blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing solid tumors. The company was incorporated in 2020 and is based in Carlton, Australia.
FAQ
What Is the Chimeric Therapeutics (CHM) Stock Price Today?
The Chimeric Therapeutics stock price today is 0.13 AUD.
What Stock Exchange Does Chimeric Therapeutics Trade On?
Chimeric Therapeutics is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Chimeric Therapeutics?
The stock symbol for Chimeric Therapeutics is "CHM."
What Is the Chimeric Therapeutics Market Cap?
As of today, Chimeric Therapeutics market cap is 6.48M AUD.
What Is Chimeric Therapeutics's Earnings Per Share (TTM)?
The Chimeric Therapeutics EPS (TTM) is -0.76.
From a Technical Analysis Perspective, Is CHM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Chimeric Therapeutics Stock Split?
Chimeric Therapeutics has split 2 times.
What is the current trading status of Chimeric Therapeutics (CHM)?
As of May 20, 2026, Chimeric Therapeutics (CHM) is trading at a price of 0.13 AUD, with a previous close of 0.13 AUD. The stock has fluctuated within a day range of 0.13 AUD to 0.13 AUD, while its 52-week range spans from 0.10 AUD to 0.60 AUD.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.